People's Health Press
ISSN 2096-2738 CN 11-9370/R

Source Journal for Chinese Scientific and Technical Papers and Citations
Source Journal for Annual Report for Chinese Academic Journal Impact Factors(2022)
Indexed Journals in the Database of the Chemical Abstracts Service (CAS), USA
Indexed Journals in the Database of the Japan Science and Technology Agency (JST)

  • Official WeChat

  • Official Weibo

  • Official headlines

Electronic Journal of Emerging Infectious Diseases ›› 2024, Vol. 9 ›› Issue (6): 92-97.doi: 10.19871/j.cnki.xfcrbzz.2024.06.016

• Standards/Guidelines/ConsensusStandards/Consensus • Previous Articles     Next Articles

2024 WHO Tuberculosis Report: key data analysis for China and the global world

Li Yuanyuan1, Xie Jingjing1, Li Shutao1, Su Dongdong1, Zheng Tian1, Lu Puxuan2, Peng Yi1   

  1. 1. Department of Tuberculosis, Xinjiang Uyghur Autonomous Region Infectious Disease Hospital, Xinjiang Urumqi 830001, China;
    2. Department of Radiology, Shenzhen Center for Chronic Disease Control, Guangdong Shenzhen 518020, China
  • Received:2024-11-02 Online:2025-01-25 Published:2025-01-25

Abstract: It is estimated that in 2023, there were 10.8 million new cases of tuberculosis globally, with China recording 741 000 new cases (accounting for 6.8% of the global incidence rate), ranking third among the 30 high-burden countries for tuberculosis. The global death toll from tuberculosis was approximately 1.25 million, with an estimated 27 000 deaths in China. In 2023, there were about 400 000 cases of multi-drug resistant/rifampin-resistant tuberculosis globally, with approximately 29 000 cases in China. From 2015 to 2023, the incidence rate of tuberculosis decreased by 8.3%, and the net decrease in deaths was 23%. However, about 50% of tuberculosis patients and their families still face catastrophic expenses, which is far from the 2025 milestone set by the World Health Organization's End TB Strategy. In 2023, global tuberculosis diagnosis and treatment services further recovered, with 8.2 million new cases of tuberculosis diagnosed and reported globally, the highest since the WHO began monitoring global tuberculosis data in 1995. However, there is still a gap of approximately 2.7 million cases between the reported and estimated numbers. Against the backdrop of a rising global tuberculosis burden, it is urgent to strengthen resource investment and multi-party cooperation. The WHO calls on countries to increase their efforts in tuberculosis prevention and control to address this increasingly severe global health threat. Compared to global data, China has made certain progress in tuberculosis prevention and control, with a relatively high treatment success rate and wide coverage. However, China still has a significant gap with global goals in terms of drug resistance monitoring, economic support, and preventive treatment. In the future, it will require joint efforts from the government and all sectors of society to continuously increase investment and prevention and control efforts to achieve the strategic goal of "ending tuberculosis".

Key words: Tuberculosis, Report, The end tuberculosis strategy, Data analysis

CLC Number: